Limei Hu
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- RNA modifications and cancer
- Circular RNAs in diseases
- Mitochondrial Function and Pathology
Papers in
-
- Gene expression and cancer classification 10
- RNA Research and Splicing 6
- Molecular Biology Techniques and Applications 6
-
- MicroRNA in disease regulation 8
- Cancer, Hypoxia, and Metabolism 6
- Co-authors
- David Cogdell (21 shared papers)Gregory N. Fuller (8 shared papers)Ilya Shmulevich (13 shared papers)Latha Ramdas (7 shared papers)Kexin Chen (10 shared papers)Anil K. Sood (11 shared papers)Da Yang (10 shared papers)Stanley R. Hamilton (12 shared papers)
- Journals
- Oncogene (3 papers)Cancer Research (3 papers)Proceedings of the National Academy of Sciences (3 papers)IEEE Transactions on Aerospace and Electronic Systems (3 papers)BioTechniques (3 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Limei Hu
84 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 140
- Cancer Research 1.2k
- Molecular Biology 2.0k
- Oncology 569
- Endocrinology, Diabetes and Metabolism 297
- Nephrology 107
Countries citing papers authored by Limei Hu
This map shows the geographic impact of Limei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limei Hu more than expected).
Fields of papers citing papers by Limei Hu
This network shows the impact of papers produced by Limei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limei Hu. The network helps show where Limei Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Limei Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 336 | |
| 2 | 2013 | 318 | |
| 3 | Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. | 2003 | 165 |
| 4 | 2009 | 154 | |
| 5 | 2004 | 148 | |
| 6 | 2011 | 132 | |
| 7 | 2014 | 118 | |
| 8 | 2006 | 110 | |
| 9 | 2015 | 104 | |
| 10 | 2009 | 101 | |
| 11 | 2012 | 98 | |
| 12 | 2015 | 96 | |
| 13 | 2014 | 94 | |
| 14 | 2016 | 88 | |
| 15 | 2015 | 70 | |
| 16 | 2012 | 69 | |
| 17 | 2021 | 68 | |
| 18 | 2011 | 66 | |
| 19 | 2014 | 65 | |
| 20 | 2002 | 63 |
About Limei Hu
Limei Hu is a scholar working on Molecular Biology, Cancer Research, Computer Networks and Communications, Pulmonary and Respiratory Medicine and Oncology, having authored 90 papers that have together received 3.6k indexed citations. Recurring topics across this work include Gene expression and cancer classification (10 papers), MicroRNA in disease regulation (8 papers), RNA Research and Splicing (6 papers), Age of Information Optimization (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), Growth Hormone and Insulin-like Growth Factors (6 papers), Molecular Biology Techniques and Applications (6 papers) and Congenital Heart Disease Studies (5 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (2.0k citations), Oncology (569 citations), Endocrinology, Diabetes and Metabolism (297 citations) and Nephrology (107 citations). Limei Hu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include David Cogdell, Gregory N. Fuller, Ilya Shmulevich, Latha Ramdas, Kexin Chen, Anil K. Sood, Da Yang, Stanley R. Hamilton, Ping Ji and Xishan Hao. Their work appears in journals such as Oncogene, Cancer Research, Proceedings of the National Academy of Sciences, IEEE Transactions on Aerospace and Electronic Systems and BioTechniques.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.